These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30790072)

  • 1. Three-dimensional pattern of extraretinal neovascular development in retinopathy of prematurity.
    Mangalesh S; Bleicher ID; Chen X; Viehland C; LaRocca F; Izatt JA; Freedman SF; Hartnett ME; Toth CA
    Graefes Arch Clin Exp Ophthalmol; 2019 Apr; 257(4):677-688. PubMed ID: 30790072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot optical coherence tomography angiography classification of retinal neovascularization in retinopathy of prematurity.
    Chen X; Imperio R; Viehland C; Patel PR; Tran-Viet D; Mangalesh S; Prakalapakorn SG; Freedman SF; Izatt JA; Toth CA;
    Sci Rep; 2024 Jan; 14(1):568. PubMed ID: 38177160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Visualization Highlighting Retinal Changes in Retinopathy of Prematurity From 3-Dimensional Optical Coherence Tomography Data.
    Mangalesh S; Seely KR; Tran-Viet D; Tai V; Chen X; Prakalapakorn SG; Freedman SF; Toth CA;
    JAMA Ophthalmol; 2022 Jul; 140(7):725-729. PubMed ID: 35616956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal fluorescein angiographic changes following intravitreal anti-VEGF therapy.
    Henaine-Berra A; Garcia-Aguirre G; Quiroz-Mercado H; Martinez-Castellanos MA
    J AAPOS; 2014 Apr; 18(2):120-3. PubMed ID: 24698606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auto-Processed Retinal Vessel Shadow View Images From Bedside Optical Coherence Tomography to Evaluate Plus Disease in Retinopathy of Prematurity.
    Seely KR; Wang KL; Tai V; Prakalapakorn SG; Chiu SJ; Viehland C; Grace S; Izatt JA; Freedman SF; Toth CA
    Transl Vis Sci Technol; 2020 Aug; 9(9):16. PubMed ID: 32879772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity.
    Karkhaneh R; Khodabande A; Riazi-Eafahani M; Roohipoor R; Ghassemi F; Imani M; Dastjani Farahani A; Ebrahimi Adib N; Torabi H
    Acta Ophthalmol; 2016 Sep; 94(6):e417-20. PubMed ID: 27009449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of optical coherence tomography biomarkers to differentiate favourable and unfavourable responders to intravitreal anti-vascular endothelial growth factor treatment in retinopathy of prematurity.
    Belenje A; Reddy RU; Parmeswarappa DC; Padhi TR; Subbarao B; Jalali S
    Eye (Lond); 2024 Apr; 38(6):1097-1103. PubMed ID: 37968517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
    Sankar MJ; Sankar J; Mehta M; Bhat V; Srinivasan R
    Cochrane Database Syst Rev; 2016; 2():CD009734. PubMed ID: 26932750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal low-dosage bevacizumab for retinopathy of prematurity.
    Harder BC; von Baltz S; Jonas JB; Schlichtenbrede FC
    Acta Ophthalmol; 2014 Sep; 92(6):577-81. PubMed ID: 24020921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinical study on intravitreous injection of ranibizumab for aggressive posterior retinopathy of prematurity].
    Tian R; Zhang G; Tang S; Guo J; Tan W
    Zhonghua Yan Ke Za Zhi; 2015 Nov; 51(11):822-5. PubMed ID: 26850583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extending Peripheral Retinal Vascularization in Retinopathy of Prematurity Through Regulation of VEGF Signaling.
    Sauer L; Chandler M; Hartnett ME
    Am J Ophthalmol; 2024 Apr; 260():190-199. PubMed ID: 38141904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of intravitreal aflibercept monotherapy in retinopathy of prematurity evaluated by periodic fluorescence angiography and optical coherence tomography.
    Vural A; Perente İ; Onur İU; Eriş E; Seymen Z; Hergünsel GO; Salihoğlu Ö; Yiğit FU
    Int Ophthalmol; 2019 Oct; 39(10):2161-2169. PubMed ID: 30478752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Vascular Arrest as a Predictor of Bevacizumab Treatment Failure in Retinopathy of Prematurity.
    Toy BC; Schachar IH; Tan GS; Moshfeghi DM
    Ophthalmology; 2016 Oct; 123(10):2166-75. PubMed ID: 27506484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involution of retinopathy of prematurity and neurodevelopmental outcomes after intravitreal bevacizumab treatment.
    Chang YS; Chen YT; Lai TT; Chou HC; Chen CY; Hsieh WS; Yang CM; Yeh PT; Tsao PN
    PLoS One; 2019; 14(10):e0223972. PubMed ID: 31618256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitreous Bands Identified by Handheld Spectral-Domain Optical Coherence Tomography Among Premature Infants.
    Zepeda EM; Shariff A; Gillette TB; Grant L; Ding L; Tarczy-Hornoch K; Cabrera MT
    JAMA Ophthalmol; 2018 Jul; 136(7):753-758. PubMed ID: 29799932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating Retinal Detachment and Retinoschisis Using Handheld Optical Coherence Tomography in Stage 4 Retinopathy of Prematurity.
    Chen X; Prakalapakorn SG; Freedman SF; Vajzovic L; Toth CA
    JAMA Ophthalmol; 2020 Jan; 138(1):81-85. PubMed ID: 31774474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow progressive perifoveal vascular formation in an infant with aggressive posterior retinopathy of prematurity.
    Chen X; Imperio R; Seely KR; Viehland C; Izatt JA; Prakalapakorn SG; Freedman SF; Toth CA
    J AAPOS; 2020 Oct; 24(5):323-326. PubMed ID: 33045380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macular morphology following unilateral bevacizumab injection for retinopathy of prematurity: an OCT study.
    Clark A; Wright T; Isaac M; Westall C; Mireskandari K; Tehrani NN
    J AAPOS; 2017 Dec; 21(6):499-501.e1. PubMed ID: 29079216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of retinal vascularization in retinopathy of prematurity regressed after intravitreal ranibizumab monotherapy or without treatment based on fluorescein angiography.
    Wu L; Li M; Wang L; Yan H; Zhou Z; Fan J; Zhou Y; Gou K; Guo C; Wang Y; Zhang Z
    Sci Rep; 2023 Nov; 13(1):19946. PubMed ID: 37968276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on Anti-Vascular Endothelial Growth Factor Safety for Retinopathy of Prematurity.
    Enríquez AB; Avery RL; Baumal CR
    Asia Pac J Ophthalmol (Phila); 2020; 9(4):358-368. PubMed ID: 32694348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.